Global Alpha Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Global Alpha Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-216,655	Closed	-$2.33M	–	37
2016 Q2	$2.33M	Buy	216,655 +20,700	+11%	+$228K	1.52%	30
2016 Q1	$2.06M	Sell	195,955 -85,500	-30%	-$939K	1.55%	34
2015 Q4	$3.33M	Hold	281,455	–	–	2.47%	24
2015 Q3	$3.29M	Buy	281,455 +49,800	+21%	+$660K	2.63%	21
2015 Q2	$3.34M	Buy	+231,655	New	+$3.34M	2.7%	18
2013 Q4	$1.38M	Buy	107,455 +5,000	+5%	+$59.7K	2.13%	25
2013 Q3	$1.28M	Buy	+102,455	New	+$1.43M	2.09%	28

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Global Alpha Capital Management's LFCR Position: Q3 2016 in Review

Global Alpha Capital Management sold out of Lifecore Biomedical (LFCR) in Q3 2016, closing a stake of 216,655 shares — an estimated $2.33M sold.

Global Alpha Capital Management first reported a position in LFCR in Q3 2013 and held it in 7 quarters. The position peaked at $3.34M in Q2 2015. 93 funds tracked by Wall St. Rank hold LFCR as of Q3 2016.

Global Alpha Capital Management reported no remaining Lifecore Biomedical position as of Q3 2016 after selling out during the quarter.
Global Alpha Capital Management sold 216,655 Lifecore Biomedical shares in Q3 2016, an estimated $2.33M.
Global Alpha Capital Management first reported a position in Lifecore Biomedical in Q3 2013 and held it in 7 quarters.
Global Alpha Capital Management's Lifecore Biomedical position peaked at $3.34M in Q2 2015.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2016.

Based on Global Alpha Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.